1. Escitalopram v dlhodobej liečbe endogénnej depresie u starších pacientov

1. Escitalopram v dlhodobej liečbe endogénnej depresie u starších pacientov

Escitalopram in the Long-Term Treatment of Major Depressive Disorder in Elderly Patients (2005 - 2006)

The primary aim was to investigate the long-term safety and tolerability of escitalopram (10 or 20 mg/day) treatment of elderly patients suffering from major depressive disorder. The secondary aim was to examine response to treatment, as measured by change in the Montgomery-Åsberg Depression Rating Scale (MADRS) total score from study entry to each visit, using observed cases.